Search for: "IN RE CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENT LITIGATION"
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
9 May 2012, 8:57 pm
(under the caption In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation), taking the occasion to expound on both the proper consideration of the evidence proffered to support an obviousness determination as well as the evidentiary burdens and their proper application. [read post]
28 Feb 2013, 9:36 pm
By Andrew Williams -- On the first day of February, the Federal Circuit rejected Impax's efforts to get out from under a preliminary injunction in a case captioned In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation. [read post]
20 May 2011, 4:01 pm
In Re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, C.A. [read post]
12 Apr 2011, 7:38 am
In Re Cyclobenzaprine Hydrochloride Extended Release Capsule Patent Litigation, C.A. [read post]
24 Oct 2013, 9:26 am
In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, C.A. [read post]
24 May 2011, 1:34 pm
In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, 09-MD-2118-SLR (D. [read post]
7 Jul 2011, 4:50 pm
In Re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, No. [read post]
19 Mar 2010, 8:49 am
In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, MDL No. 09-2118 (D. [read post]
24 May 2011, 2:13 pm
In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, 09-MD-2118-SLR (D. [read post]
7 Feb 2011, 6:52 pm
In In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, 2010 U.S. [read post]
22 Jan 2012, 2:47 pm
In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, No. 09-MD-2118-SLR (D. [read post]
17 Jan 2012, 3:37 pm
In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig., Civ. [read post]
18 Dec 2009, 9:59 am
(patent infringement) 12/2: In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation (patent infringement) 12/2: Samsung Electronics Co., Ltd. v. [read post]
26 May 2011, 7:50 am
" In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, 1-09-md-02118 (DED May 24, 2011, Order) (Robinson, J.) [read post]
4 Dec 2013, 4:03 am
(In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig.), 676 F.3d 1063 (Fed. [read post]
15 Aug 2012, 9:35 am
See In Re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, 676 F.3d 1063 (Fed. [read post]
31 May 2011, 8:38 pm
– response to OPPI vice chairman’s interview with the Financial Express (Spicy IP) Japan: IP High Court guidance on availability of patent term extension for new forms of previously approved medicine (The SPC Blog) Japan – IP High Court offers guidance on patent term extension for combination of known drugs (The SPC Blog) Switzerland – The Swiss Federal Supreme Court approves new dosage regime as patentable subject matter in Swiss Type Claims under… [read post]
13 Jul 2011, 3:04 am
(BIOtechNOW) US: PTO agrees to reexamine broad codon-optimization patents (Holman’s Biotech IP Blog) US: Inherently incomprehensible: Does the CAFC’s view of inherency in In Re Kao spell the end of second medical use patents in the USA? [read post]
9 May 2016, 12:27 pm
Cir. 2009) (internal quotation marksomitted)); In re Cyclobenzaprine Hydrochloride Extended–Release Capsule Patent Litig., 676 F.3d 1063, 1068–69(Fed. [read post]
7 Aug 2013, 8:50 am
See, e.g., In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig., 676 F.3d 1063, 1076 (Fed. [read post]
